Integrated Cartilage Repair

综合软骨修复

基本信息

  • 批准号:
    10221602
  • 负责人:
  • 金额:
    $ 35.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-13 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Osteoarthritis, or degeneration of cartilage, is one of the most prevalent joint diseases and remains the most common cause of work-related disabilities in this country. Current osteoarthritis treatment options often fail due to lack of integration between the cartilage graft and the host tissues, including both the surrounding cartilage and underlying bone. Therefore, there exists an unmet clinical need for integrative solutions for cartilage repair. The objective of the proposal is to determine the efficacy of an integrative nanofiber cup system in promoting graft-cartilage and graft-bone integration. It is hypothesized that native cartilage integration will be facilitated by controlling chondrocyte migration to the graft-cartilage junction, and osteointegration will be enhanced by optimizing calcium phosphate (CaP) nanoparticle bioactivity, concentration and spatial distribution. To test this hypothesis, the nanofiber cup system will be evaluated both in vitro (Aims 1 and 2) and in vivo (Aim 3) with a hydrogel-based cartilage graft that exhibits mechanical properties within the range of articular cartilage. An osteochondral explant model will be used to test both graft-cartilage and graft-bone integration in vitro, while a clinically relevant rabbit osteoarthritis model will be used to test host tissue integration in vivo. In addition to evaluating cell and tissue phenotypes via immunohistochemistry and biochemical assays, other functional outcomes such as integration strength and quantitative compositional mapping across tissue boundaries will also be used to determine efficacy in vitro and in vivo. In addition to targeting a clinically significant problem, the proposed approach represents a new paradigm in cartilage repair. The nanofiber integration system is novel because of its: 1) unique nanofiber-based cup design, 2) ability to promote simultaneous graft-cartilage and graft-bone integration, and 3) compatibility with a variety of cartilage grafts. This innovative approach for integrated cartilage repair will enable the restoration of cartilage integrity and long-term function. Moreover, it will help to prevent further joint degeneration and thereby reduce the need for aggressive and often suboptimal interventions (e.g. total joint replacements and related revision surgeries). Successful completion of the planned studies will lead to the development of a new generation of nanotechnology-based fixation devices for the treatment of soft tissue injuries.
项目摘要 骨关节炎或软骨退化是最普遍的关节疾病之一,并且仍然是最常见的关节疾病。 这是这个国家工作残疾的常见原因目前的骨关节炎治疗方案往往失败, 软骨移植物和宿主组织之间缺乏整合,包括周围的软骨 和下面的骨头因此,对于软骨修复的综合解决方案存在未满足的临床需求。 该提案的目的是确定一个综合性的杯子系统在促进 移植物-软骨和移植物-骨整合。据推测,天然软骨整合将促进 控制软骨细胞向移植物-软骨连接处的迁移, 优化磷酸钙(CaP)纳米颗粒的生物活性、浓度和空间分布。为了验证这一 假设,将在体外(目标1和2)和体内(目标3)对髋臼杯系统进行评价, 基于水凝胶的软骨移植物,其表现出关节软骨范围内的机械性能。一个 骨软骨移植模型将用于测试移植物-软骨和移植物-骨的体外整合, 临床相关的兔骨关节炎模型将用于测试体内宿主组织整合。除了 通过免疫组织化学和生物化学测定评价细胞和组织表型, 诸如整合强度和跨组织边界的定量成分映射的结果将 也可用于测定体外和体内的功效。 除了针对临床上重要的问题,所提出的方法代表了一种新的范例, 软骨修复该集成系统是新颖的,因为其:1)独特的基于纳米纤维的杯设计, 2)促进同时移植物-软骨和移植物-骨整合的能力,和3)与各种 软骨移植这种创新的综合软骨修复方法将使软骨的恢复 完整性和长期功能。此外,这将有助于防止进一步的关节退化,从而减少 需要积极的和通常次优的干预措施(例如全关节置换和相关翻修 手术)。成功完成计划的研究将导致开发新一代的 用于治疗软组织损伤的基于纳米技术的固定装置。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HELEN H LU其他文献

HELEN H LU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HELEN H LU', 18)}}的其他基金

Dental-Biomedical Engineering Scholars Training (D-BEST) Program
牙科生物医学工程学者培训(D-BEST)计划
  • 批准号:
    10714037
  • 财政年份:
    2023
  • 资助金额:
    $ 35.93万
  • 项目类别:
Integrated Cartilage Repair
综合软骨修复
  • 批准号:
    10466801
  • 财政年份:
    2018
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    8067092
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    8271269
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    8477129
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Biphasic Nanofiber-based Scaffold for Tendon-to-Bone Integration
用于肌腱与骨整合的双相纳米纤维支架
  • 批准号:
    7514940
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Biphasic Nanofiber-based Scaffold for Tendon-to-Bone Integration
用于肌腱与骨整合的双相纳米纤维支架
  • 批准号:
    7645643
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    7533812
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    7645644
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:
Interface Tissue Engineering for Soft Tissue-to-Bone Integration
软组织与骨整合的界面组织工程
  • 批准号:
    8660647
  • 财政年份:
    2008
  • 资助金额:
    $ 35.93万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 35.93万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 35.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了